HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: FDA Seeks Cosmetics Comments; L’Oreal/Magic Deal Approved; More

This article was originally published in The Rose Sheet

Executive Summary

FDA will reopen comments for cosmetics regarding its final guidance on Investigational New Drug Applications. China’s Ministry of Commerce approves L’Oreal’s acquisition of Magic Holdings. More.

You may also be interested in...



L’Oreal ‘Surfing’ Makeup Wave To Projected Strong Finish For FY 2016

Acquired brands NYX and Urban Decay are leading growth in L’Oreal’s makeup business, up 15% for the year to date. Strong demand for color cosmetics in the mass and luxury channels drove the firm’s Q3 sales, surpassing analyst expectations, if not L’Oreal’s.

In Brief: Coty Eyes OPI Growth; RevitaLash Is Back; Garnier Pulled From China

Coty aims to drive development of its OPI nail brand in the U.K. with the acquisition of distributor Lena White. More news in brief.

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.

Related Companies

UsernamePublicRestriction

Register

RS019129

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel